Biography
Lord Mitchell has engaged with health and social care through two debate speeches. He contributed to discussions on assisted dying and end-of-life care by sharing a personal account of his parents-in-law's circumstances, and addressed diet and weight management by discussing his own experience using GLP-1 receptor agonist medications over a two-year period.
Generated from their own Hansard record, below
“…If there had been assisted dying legislation at that time, I am certain that things would have turned out differently. We could have talked about it openly, without the fear of legal consequences. We could have engaged professional help.”
Record by topic
- Assisted dying277th of 3712.0
- Cancer503rd of 6222.0
- Heart disease & stroke324th of 3982.0
- Diabetes154th of 1902.0
- Palliative & end of life care452nd of 5682.0
What they’ve said
“…A drug that started out being used to regulate diabetes can now reduce weight. There is strong evidence that it can control the incidence of kidney and liver disease, cardiovascular issues and sleep apnoea, and reduce drug addiction and opioid inflammation. They say that it can contain ageing and even Alzheimer’s.”
Diets: Fat · 2024-10-31 · Read on Hansard ↗
Contributions reproduced under the Open Parliament Licence.